259209 25-hydroxyvitamin D (25(OH)D) Concentrations and Pathogenic Oral Bacteria in Postmenopausal Women in the Osteoporosis and Periodontal Study (OsteoPerio Study)

Sunday, October 28, 2012

Michelle Sahli, BS , Department of Social and Preventive Medicine - School of Public Health and Professions, State University of New York at Buffalo, Buffalo, NY
Jean Wactawski-Wende, PhD , Department of Social and Preventive Medicine - School of Public Health and Professions, State University of New York at Buffalo, Buffalo, NY
Pavani Ram, MD , Department of Social and Preventive Medicine - School of Public Health and Professions, State University of New York at Buffalo, Buffalo, NY
Kathleen Hovey, MS , Department of Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, The State University of New York, Buffalo, NY
Michael LaMonte, PhD, MPH , Department of Social and Preventive Medicine - School of Public Health and Professions, State University of New York at Buffalo, Buffalo, NY
Robert Genco, PhD, DDS , Department of Oral Biology, State University of New York at Buffalo, Buffalo, NY
Christopher Andrews, PhD , Department of Biostatistics, University at Buffalo, The State University of New York, Buffalo, NY
Amy Millen, PhD , Social and Preventive Medicine, School of Public Health and Health Professions, University at Buffalo, The State University of New York, Buffalo, NY
Background: Studies have found an association between 25(OH)D concentrations and periodontal disease (PD), which may be explained in part by vitamin D's antimicrobial properties. To our knowledge, no study has investigated the relationship between 25(OH)D and the prevalence of pathogenic oral bacteria, a putative cause of PD. Purpose: We examined the cross-sectional (1997-2000) relationship between plasma 25(OH)D concentrations and prevalence of pathogenic oral bacteria among postmenopausal women in the OsteoPerio ancillary study of the Buffalo center of the Women's Health Initiative. Methods: Subgingival plaque samples were assessed for the presence of Porphyromonas gingivalis, Tannerella forsythensis, Fusobacterium nucleatum, Prevotella intermedia and Campylobacter rectus. Plasma 25(OH)D concentrations were determined using chemiluminescence. Logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI) for prevalent bacteria by quintile (Q) of 25(OH)D concentration adjusting for body mass index as a potential confounder. Results: Of the 856 participants, 289 (34%) had inadequate (<50 nmol/L) 25(OH)D concentrations and 497 (58.1%) had at least one species of these oral bacteria. There was no association found between 25(OH)D concentrations and prevalence of pathogenic oral bacteria (OR (95% CI) for Q5 (high) vs. Q1 (low)= 0.95 (0.61-1.48); p for trend=0.50). This association was not modified by frequency of flossing, diabetes status, antibiotic use, smoking status or whole-mouth mean periodontal pocket depth. Conclusions: This observed lack of association may be due to the species of bacteria assessed, small effect size or a true absence of a relationship between 25(OH)D and pathogenic oral bacteria.

Learning Areas:
Chronic disease management and prevention
Epidemiology
Public health biology

Learning Objectives:
1. Assess the cross-sectional association of between plasma 25(OH)D concentrations and prevalence of any of five species of pathogenic oral bacteria. 2. Evaluate the association of plasma 25(OH)D concentrations and prevalence of any of five species of pathogenic oral bacteria differs according to levels of flossing, diabetes status, antibiotic use, smoking status or whole-mouth mean periodontal pocket depth.

Keywords: Oral Health, Epidemiology

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a graduate student in the PhD program in epidemiology and have worked on this analysis as part of my thesis work alongside Dr. Amy Millen the principle investigator on a grant examining the role of vitamin D on oral health. Among my scientific interests are epidemiology and infectious diseases.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.